Czechia· CZ-0236893
VARDESSIN
A vasopressin (argipressin) product containing argipressin acetate, registered in Czechia by ARDEZ Pharma, spol. s r.o., Kosoř. The same ATC class is registered in 10 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Vasopressin (argipressin) is registered in 10 of 19 countries.
Countries holding a registration under ATC H01BA01 (vasopressin (argipressin)), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 6 of them publish a price we can compare per daily dose
Vasopressin (argipressin) · ATC H01BA01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ARGIPRESSIN ACETATE
- Manufacturer
- ARDEZ Pharma, spol. s r.o., Kosoř
- Country
- Czechia (CZ)
- ATC code
- H01BA01
- ATC class
- Vasopressin (argipressin)
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
166 interactions on record for vasopressin (argipressin).
Graded by severity as the source publishes them — 39 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vasopressin (argipressin) · interactions on record
166 records
- 39 severe
- 125 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H01BA01
Vasopressin (argipressin), as other registers publish it.
- PolandArgipressin FarmakFarmak International Sp. z o.o.
- CzechiaEMBESINOrpha-Devel Handels und Vertriebs GmbH, Purkersdorf
- CzechiaEMBESINOrpha-Devel Handels und Vertriebs GmbH, Purkersdorf
- CzechiaEMBESINOrpha-Devel Handels und Vertriebs GmbH, Purkersdorf
- IrelandEmbesin 20 IU/ml concentrate for solution for infusionOrpha-Devel Handels und Vertriebs GmbH
- PolandEmpesinOrpha-Devel Handels und Vertriebs GmbH
- DenmarkEmpressinOrpha Devel Handels- und Vertr.
- FinlandEmpressinOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Slovakia · Vardessin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2c69ff9-780a-41f6-aa32-2abfd6dd6447 GET /v1/drugs/e2c69ff9-780a-41f6-aa32-2abfd6dd6447?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "20IU/ML",
"pack_size": "10X1ML",
"substance": "ARGIPRESSIN ACETATE",
"cz_kod_sukl": "0236893",
"product_type": "CH",
"substance_codes": "12957",
"registration_state": "B",
"registration_number": "84/444/18-C"
}See everything about vasopressin (argipressin).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.